Soleno Therapeutics Inc financial data

Symbol
SLNO on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
203 Redwood Shores Parkway, Suite 500, Redwood City, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Capnia, Inc. (to 5/11/2017)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 632 % +167%
Debt-to-equity 31.9 % -76.7%
Return On Equity -61.8 % +71.9%
Return On Assets -46.9 % +49.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.5 M shares +297%
Common Stock, Shares, Outstanding 33.3 M shares +308%
Entity Public Float 33.1 M USD +324%
Common Stock, Value, Issued 33 K USD +313%
Weighted Average Number of Shares Outstanding, Basic 36.2 M shares +283%
Weighted Average Number of Shares Outstanding, Diluted 36.2 M shares +283%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 34.5 M USD +108%
General and Administrative Expense 19.1 M USD +89.9%
Operating Income (Loss) -56.4 M USD -108%
Nonoperating Income (Expense) 4.36 M USD +1007%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -39 M USD -62%
Net Income (Loss) Attributable to Parent -52 M USD -94.9%
Earnings Per Share, Basic -2.07 USD/shares +22.8%
Earnings Per Share, Diluted -2.07 USD/shares +22.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.8 M USD +444%
Assets, Current 151 M USD +1557%
Property, Plant and Equipment, Net 27 K USD +22.7%
Operating Lease, Right-of-Use Asset 338 K USD +538%
Intangible Assets, Net (Excluding Goodwill) 8.26 M USD -19%
Other Assets, Noncurrent 165 K USD +31%
Assets 169 M USD +764%
Accounts Payable, Current 8.02 M USD +189%
Employee-related Liabilities, Current 1.23 M USD +70%
Liabilities, Current 13.5 M USD +73.5%
Operating Lease, Liability, Noncurrent 37 K USD
Liabilities 25.5 M USD +50.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -106 K USD -763%
Retained Earnings (Accumulated Deficit) -298 M USD -21.2%
Stockholders' Equity Attributable to Parent 143 M USD +5333%
Liabilities and Equity 169 M USD +764%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5 M USD -86.2%
Net Cash Provided by (Used in) Financing Activities 938 K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 33.3 M shares +308%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -127 M USD -1785%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 42.8 M USD +444%
Deferred Tax Assets, Valuation Allowance 66 M USD +15.7%
Deferred Tax Assets, Gross 67.9 M USD +13.2%
Operating Lease, Liability 347 K USD
Depreciation 14 K USD -30%
Payments to Acquire Property, Plant, and Equipment 11 K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.5 M USD -158%
Lessee, Operating Lease, Liability, to be Paid 366 K USD
Property, Plant and Equipment, Gross 101 K USD 0%
Operating Lease, Liability, Current 310 K USD +695%
Lessee, Operating Lease, Liability, to be Paid, Year Two 143 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 175 K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19 K USD
Deferred Tax Assets, Operating Loss Carryforwards 51.5 M USD +5.01%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 2.94 M USD +51.8%
Operating Lease, Payments 64 K USD -46.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 66 M USD +15.7%
Share-based Payment Arrangement, Expense 11.8 M USD +367%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%